Acute mental status changes following intrapleural instillation of quinacrine for traumatic pneumothorax

Psychosomatics

Volumn 37, Issue 1, 1996, Pages 74-78

  Weingart, Saul N ^a   Hamlett, Frank ^a   Miller, Bruce D ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEPACRINE; SCLEROSING AGENT;

ADOLESCENT; ARTICLE; CASE REPORT; FEMALE; HUMAN; INTRAPLEURAL DRUG ADMINISTRATION; PNEUMOTHORAX; PSYCHOSIS;

EID: 0030051896     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(96)71602-X     Document Type: Letter

References (24)

1. Gellhom A. Zaidenweber J, Ultmann J, et al: The use of atabrine (quinacrine) in the control of recurrent neoplastic effusions: a preliminary report. Chest 1961; 39:165-172
2. Borja ER, Pugh RP: Single-dose quinacrine (atabrine) and thoracostomy in the control of pleural effusions in patients with neoplastic diseases. Cancer 1973; 31:899-902
3. Kattwinkel J. Taussig LM, McIntosh CL, et al: Intrapleural instillation of quinacrine for recurrent pneumothorax: use in a patient with cystic fibrosis. JAMA 1973; 226:557-559
4. Jones RE, Giammona ST: Intrapleural injection of quinacrine for pneumothorax in a child with cystic fibrosis. American Journal of Diseases in Children 1976; 130:777-778
5. Larrieu AJ, Tyers GFO, Williams EH. et al: Intrapleural instillation of quinacrine for treatment of recurrent spontaneous pneumothorax. Ann Thorac Surg 1978; 28: 146-150
6. James JJ, James NS, Morgenstern M, et al: Quinacrine-induced toxic psychosis in a child (letter). Pediatr Infect Dis J 1987, 6:427
7. Janzing HMJ, Derom A, Derom M, et al: Intrapleural quinacrine instillation for recurrent pneumothorax or persistent air leak. Ann Thorac Surg 1993; 55:368-371
8. Kingsbury AN: Psychosis in cases of malaria following exhibition of Atebrin. Lancet 1934; 2:979-982
9. Rochlin DB, Smart CR, Wagner DE, et al: The control of recurrent malignant effusions using quinacrine hydrochloride Surgery Gynecolosy and Obstetrics 1964; 118:991-994
10. Gorski ED: Management of giardiasis. Am Fam Physician 1985; 32:157-164
11. McEvoy GK (ed): AHFS Drug Information 1993. Bethesvda, MD. American Society of Hospital Pharmacists, 1993, pp 48-50
12. Lindenmayer JP, Vargas P: Toxic psychosis following use of quinacrine. J Clin Psychiatry 1981; 42:162-164
13. Miller LG, Kraft IA: Quinacrine-induced psychosis in a pediatri cpatient. J Fam Practice 1991; 32:526-528
14. Gaskill HS. Fitz-Hugh T, Jr: Toxic psychosis following Atabrine. Bulletin of the United States Army Medical Department 1945; 86:63-69
15. Sapp OL: Toxic psychosis due to quinacrine and chloroquine. JAMA 1964; 187:373-375
16. Weischoltz SJ, McBride PA, Murray HW, et al: Quinacrine-induced psychiatric disturbances. South Med J 1982; 75:359-360
17. Evans RL, Khalid S, Kinney JL: Antimalarial psychosis revisited. Arch Dermatol 1984; 120:765-767
18. Moreno TJ, Green J: Quinacrine-associated mania. Mayo Ciin Proc 1989; 64:129-130
19. Litz T, Kahn RL: Toxicity of quinacrine (Atabrine) for the central nervous system. Archives of Neurology and Psychiatry 1946; 56:284-299
20. Engel GL, Romano J. Ferris EB: Effect of quinacrine (atabrine) on the central nervous system. Arch Neurol Psychiatry 1947; 58:337-350
21. Waelsch H, Nachmansohn D: On the toxicity of atabrine. Proc Soc Exp Biol Med 1943-44; 54-55: 336-338
22. Malek-Ahmadi P: Toxic psychosis following use of quinacrine. J Clin Psychiatry 1981; 42:481
23. Bjorkman S, Elisson LO. Gabrielsson J: Pharmacokinetics of quinacrine after intrapleural instillation in rabbits and man. J Pharm Pharmacol 1989; 41:160-163
24. Borda I, Krant M: Convulsions following intrapleural administration of quinacrine hydrochloride. JAMA 1967; 201:1049-1050